J. Goldman & Co’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-180,000
Closed -$439K 531
2022
Q3
$439K Sell
180,000
-1,170,000
-87% -$3.91M 0.02% 302
2022
Q2
$3.06M Sell
1,350,000
-696,400
-34% -$2.59M 0.15% 159
2022
Q1
$13.8M Buy
2,046,400
+1,986,400
+3,311% +$17M 0.63% 42
2021
Q4
$543K Buy
+60,000
New +$558K 0.03% 283
2021
Q3
Sell
-47,200
Closed -$606K 502
2021
Q2
$606K Buy
+47,200
New +$647K 0.02% 313
2020
Q4
Sell
-813,300
Closed -$6.21M 497
2020
Q3
$6.21M Buy
813,300
+500,800
+160% +$3.68M 0.42% 77
2020
Q2
$1.89M Sell
312,500
-169,900
-35% -$838K 0.12% 165
2020
Q1
$1.7M Buy
+482,400
New +$4.09M 0.2% 113

Other funds holding DBD

J. Goldman & Co's DBD Position: Q2 2022 in Review

J. Goldman & Co sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2022, closing a stake of 52,500 shares — an estimated $196K sold.

J. Goldman & Co first reported a position in DBD in Q1 2017 and held it in 3 quarters. The position peaked at $896K in Q1 2017. 169 funds tracked by Wall St. Rank hold DBD as of Q2 2022.

  • J. Goldman & Co reported no remaining Diebold Nixdorf Incorporated position as of Q2 2022 after selling out during the quarter.
  • J. Goldman & Co sold 52,500 Diebold Nixdorf Incorporated shares in Q2 2022, an estimated $196K.
  • J. Goldman & Co first reported a position in Diebold Nixdorf Incorporated in Q1 2017 and held it in 3 quarters.
  • J. Goldman & Co's Diebold Nixdorf Incorporated position peaked at $896K in Q1 2017.
  • 169 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2022.

Based on J. Goldman & Co's 13F filing for Q2 2022, filed 15 Aug 2022.